Request an Appointment
Read more about our new revolutionary approach to treating and potentially curing FSGS, called DISOT.
Autoimmune FSGS is a rare disease where the immune system produces a chemical that causes the filters in the kidneys to leak. The tiny filters, called glomeruli, become scarred. Scarring often leads to nephrotic syndrome (a disorder where the kidneys excrete extra protein in the urine), which in turn can lead to progressive renal failure. It is most common in children and teenagers.
The cause of autoimmune FSGS is unknown, but we do know that it involves a problem with the cells of the immune system.
Symptoms of autoimmune FSGS include swelling in the legs, ankles, and around the eyes. Because the body is retaining fluids, you might notice that your child is gaining weight. Another sign is foamy urine. Your child might test with high cholesterol or high blood pressure. If kidney failure is involved, your child could experience fatigue, headaches, itchy skin, a poor appetite, and vomiting. Also, with autoimmune FSGS, the body can’t hold on to protein well, making it hard for children to grow well and be healthy. High-risk treatments, such as steroids, also set children up for infections.
When kidneys are scarred, that scarring is permanent, which means your child will eventually need a kidney transplant. Unfortunately, traditional kidney transplants fail in children with autoimmune FSGS over 90% of the time. This is because the immune system attacks the donor kidney and destroys it, usually within a few weeks. Doctors at Stanford Medicine Children’s Health have developed a two-transplant approach that gives children with autoimmune FSGS a chance at a successful kidney transplant. This approach, called dual immune/solid organ transplant (DISOT), is essentially a cure for autoimmune FSGS. Once we give your child a new immune system with a stem cell transplant, it will not attack a new kidney from the same donor.
We have researched, developed, and had initial success with a two-transplant approach to treating autoimmune FSGS called dual immune/solid organ transplant (DISOT). DISOT was recently featured in the New England Journal of Medicine. We are the only hospital in the world that is currently offering this revolutionary approach.
DISOT is a stem cell transplant, which provides your child with a new immune system, followed by a kidney transplant from the same donor, usually a parent. Since your child’s new immune system recognizes its new kidney, it isn’t likely to reject it.
We are able to use a haploidentical (partially matched) donor, which is usually a parent. We selectively eliminate alpha/beta T-cells (the immune system’s fighter cells) from the donor’s stem cells to reduce the risk of graft-versus-host disease, which is otherwise a frequent complication of these kinds of transplants. This revolutionary stem cell transplant method is led by Alice Bertaina, MD, PhD—the worldwide pioneer and foremost expert in alpha/beta T-cell depleted haploidentical stem cell transplantation. Even though alpha/beta T-cells are removed, these cells recover 60–90 days after transplant, so your child regains his or her full immune function.
There are several benefits to our novel dual immune/solid organ transplant (DISOT) approach:
Yes, and it has been successful. One patient with severe FSGS now has normal kidney function and is off all medications. He reports feeling well, and he is gaining physical strength and energy.
Yes. They should be a candidate, and we are happy to evaluate your child. Have their nephrologist contact us at (650) 498-4905.
Your child’s first kidney transplant failed because their immune system was still programmed by the FSGS. Because we replace your child’s immune system before the kidney transplant—basically wiping out the FSGS—the risk of rejection is nearly nonexistent.
Most important, because we offer a chance at a cure of your child’s kidney disease and immune problems. We also are experts at what we do. Stanford Medicine Children’s Health has performed over 1,000 stem cell transplants since our program’s inception, and we are a national leader in pediatric kidney transplant volumes. Our program in alpha/beta T-cell depletion, which reduces the risk of the stem cell transplant being rejected as well as the risk of graft-versus-host-disease, is the biggest in the country.
Also, when children with FSGS come to us, they receive care from a multidisciplinary team of internationally respected stem cell and kidney transplant specialists, nephrologists, neuroimmunologists, oncologists, and other specialists. With our revolutionary DISOT method, we give hope to parents who experienced little before.
A great resource to learn more about living with kidney disease, particularly nephrotic syndrome (which can be caused by FSGS), is Nephcure Kidney International. It’s a site created by families for families with nephrotic syndrome and FSGS. You can also learn more on the National Kidney Foundation’s FSGS page.
Learn more about our pediatric stem cell transplant, kidney transplant, and kidney care programs at Stanford Medicine Children’s Health.
Have your child’s nephrologist contact us at (650) 498-4905.
Connect with us:
Download our App: